3.21.1 html 189 396 1 false 71 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.beyondspringpharma.com/20201231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.beyondspringpharma.com/20201231/role/statement-consolidated-balance-sheets- Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.beyondspringpharma.com/20201231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://www.beyondspringpharma.com/20201231/role/statement-consolidated-statements-of-comprehensive-loss- Consolidated Statements of Comprehensive Loss Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Shareholders' Equity (Deficit) Sheet http://www.beyondspringpharma.com/20201231/role/statement-consolidated-statements-of-shareholders-equity-deficit Consolidated Statements of Shareholders' Equity (Deficit) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.beyondspringpharma.com/20201231/role/statement-consolidated-statements-of-cash-flows- Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Nature of the Business Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-1-nature-of-the-business Note 1 - Nature of the Business Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Collaboration Revenue Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-3-collaboration-revenue Note 3 - Collaboration Revenue Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Property and Equipment, Net Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-4-property-and-equipment-net Note 4 - Property and Equipment, Net Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Long-term Loans Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-5-longterm-loans Note 5 - Long-term Loans Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Related Party Transactions Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-6-related-party-transactions Note 6 - Related Party Transactions Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Income Taxes Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-7-income-taxes Note 7 - Income Taxes Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Net Loss Per Share Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-8-net-loss-per-share Note 8 - Net Loss Per Share Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Share based Compensation Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-9-share-based-compensation Note 9 - Share based Compensation Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Employee Defined Contribution Plan Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-10-employee-defined-contribution-plan Note 10 - Employee Defined Contribution Plan Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Restricted Net Assets Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-11-restricted-net-assets Note 11 - Restricted Net Assets Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Lease Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-12-lease- Note 12 - Lease Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Supplemental Balance Sheet Information Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-13-supplemental-balance-sheet-information Note 13 - Supplemental Balance Sheet Information Notes 19 false false R20.htm 019 - Disclosure - Note 14 - Contingently Redeemable Noncontrolling Interests Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-14-contingently-redeemable-noncontrolling-interests- Note 14 - Contingently Redeemable Noncontrolling Interests Notes 20 false false R21.htm 020 - Disclosure - Note 15 - Forward Liability Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-15-forward-liability- Note 15 - Forward Liability Notes 21 false false R22.htm 021 - Disclosure - Note 16 - Commitments and Contingencies Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-16-commitments-and-contingencies Note 16 - Commitments and Contingencies Notes 22 false false R23.htm 022 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.beyondspringpharma.com/20201231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.beyondspringpharma.com/20201231/role/statement-note-2-summary-of-significant-accounting-policies 23 false false R24.htm 023 - Disclosure - Note 1 - Nature of the Business (Tables) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-1-nature-of-the-business-tables Note 1 - Nature of the Business (Tables) Tables http://www.beyondspringpharma.com/20201231/role/statement-note-1-nature-of-the-business 24 false false R25.htm 024 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://www.beyondspringpharma.com/20201231/role/statement-note-2-summary-of-significant-accounting-policies 25 false false R26.htm 025 - Disclosure - Note 3 - Collaboration Revenue (Tables) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-3-collaboration-revenue-tables Note 3 - Collaboration Revenue (Tables) Tables http://www.beyondspringpharma.com/20201231/role/statement-note-3-collaboration-revenue 26 false false R27.htm 026 - Disclosure - Note 4 - Property and Equipment, Net (Tables) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-4-property-and-equipment-net-tables Note 4 - Property and Equipment, Net (Tables) Tables http://www.beyondspringpharma.com/20201231/role/statement-note-4-property-and-equipment-net 27 false false R28.htm 027 - Disclosure - Note 5 - Long-term Loans (Tables) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-5-longterm-loans-tables Note 5 - Long-term Loans (Tables) Tables http://www.beyondspringpharma.com/20201231/role/statement-note-5-longterm-loans 28 false false R29.htm 028 - Disclosure - Note 7 - Income Taxes (Tables) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-7-income-taxes-tables Note 7 - Income Taxes (Tables) Tables http://www.beyondspringpharma.com/20201231/role/statement-note-7-income-taxes 29 false false R30.htm 029 - Disclosure - Note 8 - Net Loss Per Share (Tables) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-8-net-loss-per-share-tables Note 8 - Net Loss Per Share (Tables) Tables http://www.beyondspringpharma.com/20201231/role/statement-note-8-net-loss-per-share 30 false false R31.htm 030 - Disclosure - Note 9 - Share based Compensation (Tables) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-9-share-based-compensation-tables Note 9 - Share based Compensation (Tables) Tables http://www.beyondspringpharma.com/20201231/role/statement-note-9-share-based-compensation 31 false false R32.htm 031 - Disclosure - Note 12 - Lease (Tables) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-12-lease-tables Note 12 - Lease (Tables) Tables http://www.beyondspringpharma.com/20201231/role/statement-note-12-lease- 32 false false R33.htm 032 - Disclosure - Note 13 - Supplemental Balance Sheet Information (Tables) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-13-supplemental-balance-sheet-information-tables Note 13 - Supplemental Balance Sheet Information (Tables) Tables http://www.beyondspringpharma.com/20201231/role/statement-note-13-supplemental-balance-sheet-information 33 false false R34.htm 033 - Disclosure - Note 14 - Contingently Redeemable Noncontrolling Interests (Tables) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-14-contingently-redeemable-noncontrolling-interests-tables Note 14 - Contingently Redeemable Noncontrolling Interests (Tables) Tables http://www.beyondspringpharma.com/20201231/role/statement-note-14-contingently-redeemable-noncontrolling-interests- 34 false false R35.htm 034 - Disclosure - Note 1 - Nature of the Business (Details Textual) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-1-nature-of-the-business-details-textual Note 1 - Nature of the Business (Details Textual) Details http://www.beyondspringpharma.com/20201231/role/statement-note-1-nature-of-the-business-tables 35 false false R36.htm 035 - Disclosure - Note 1 - Nature of the Business - Schedule of Subsidiaries (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-1-nature-of-the-business-schedule-of-subsidiaries-details Note 1 - Nature of the Business - Schedule of Subsidiaries (Details) Details 36 false false R37.htm 036 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://www.beyondspringpharma.com/20201231/role/statement-note-2-summary-of-significant-accounting-policies-tables 37 false false R38.htm 037 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Useful Life of Property, Plant, and Equipment (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-2-summary-of-significant-accounting-policies-useful-life-of-property-plant-and-equipment-details Note 2 - Summary of Significant Accounting Policies - Useful Life of Property, Plant, and Equipment (Details) Details 38 false false R39.htm 038 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Schedule of Fair Value of Assets and Liabilities Measured On Recurring Basis (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-2-summary-of-significant-accounting-policies-schedule-of-fair-value-of-assets-and-liabilities-measured-on-recurring-basis-details Note 2 - Summary of Significant Accounting Policies - Schedule of Fair Value of Assets and Liabilities Measured On Recurring Basis (Details) Details 39 false false R40.htm 039 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Assumptions used to estimate the fair value of the forward liability (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-2-summary-of-significant-accounting-policies-assumptions-used-to-estimate-the-fair-value-of-the-forward-liability-details Note 2 - Summary of Significant Accounting Policies - Assumptions used to estimate the fair value of the forward liability (Details) Details 40 false false R41.htm 040 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Reconciliation of Changes in Fair Value (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-2-summary-of-significant-accounting-policies-reconciliation-of-changes-in-fair-value-details Note 2 - Summary of Significant Accounting Policies - Reconciliation of Changes in Fair Value (Details) Details 41 false false R42.htm 041 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Property and Equipment by Geographical Location (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-2-summary-of-significant-accounting-policies-property-and-equipment-by-geographical-location-details Note 2 - Summary of Significant Accounting Policies - Property and Equipment by Geographical Location (Details) Details 42 false false R43.htm 042 - Disclosure - Note 3 - Collaboration Revenue (Details Textual) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-3-collaboration-revenue-details-textual Note 3 - Collaboration Revenue (Details Textual) Details http://www.beyondspringpharma.com/20201231/role/statement-note-3-collaboration-revenue-tables 43 false false R44.htm 043 - Disclosure - Note 3 - Collaboration Revenue - Schedule of Collaboration Revenue (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-3-collaboration-revenue-schedule-of-collaboration-revenue-details Note 3 - Collaboration Revenue - Schedule of Collaboration Revenue (Details) Details 44 false false R45.htm 044 - Disclosure - Note 4 - Property and Equipment, Net (Details Textual) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-4-property-and-equipment-net-details-textual Note 4 - Property and Equipment, Net (Details Textual) Details http://www.beyondspringpharma.com/20201231/role/statement-note-4-property-and-equipment-net-tables 45 false false R46.htm 045 - Disclosure - Note 4 - Property and Equipment, Net - Schedule of Property and Equipment (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-4-property-and-equipment-net-schedule-of-property-and-equipment-details Note 4 - Property and Equipment, Net - Schedule of Property and Equipment (Details) Details 46 false false R47.htm 046 - Disclosure - Note 5 - Long-term Loans (Details Textual) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-5-longterm-loans-details-textual Note 5 - Long-term Loans (Details Textual) Details http://www.beyondspringpharma.com/20201231/role/statement-note-5-longterm-loans-tables 47 false false R48.htm 047 - Disclosure - Note 5 - Long-term Loans - Schedule of Maturities (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-5-longterm-loans-schedule-of-maturities-details Note 5 - Long-term Loans - Schedule of Maturities (Details) Details 48 false false R49.htm 048 - Disclosure - Note 6 - Related Party Transactions (Details Textual) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-6-related-party-transactions-details-textual Note 6 - Related Party Transactions (Details Textual) Details http://www.beyondspringpharma.com/20201231/role/statement-note-6-related-party-transactions 49 false false R50.htm 049 - Disclosure - Note 7 - Income Taxes (Details Textual) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-7-income-taxes-details-textual Note 7 - Income Taxes (Details Textual) Details http://www.beyondspringpharma.com/20201231/role/statement-note-7-income-taxes-tables 50 false false R51.htm 050 - Disclosure - Note 7 - Income Taxes - Components of Losses Before Income Taxes (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement--note-7-income-taxes-components-of-losses-before-income-taxes-details Note 7 - Income Taxes - Components of Losses Before Income Taxes (Details) Details 51 false false R52.htm 051 - Disclosure - Note 7 - Income Taxes - Reconciliation of Income Tax Expenses (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-7-income-taxes-reconciliation-of-income-tax-expenses-details Note 7 - Income Taxes - Reconciliation of Income Tax Expenses (Details) Details 52 false false R53.htm 052 - Disclosure - Note 7 - Income Taxes - Deferred Tax Assets (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-7-income-taxes-deferred-tax-assets-details Note 7 - Income Taxes - Deferred Tax Assets (Details) Details 53 false false R54.htm 053 - Disclosure - Note 7 - Income Taxes - Unrecognized Tax Benefits (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-7-income-taxes-unrecognized-tax-benefits-details Note 7 - Income Taxes - Unrecognized Tax Benefits (Details) Details 54 false false R55.htm 054 - Disclosure - Note 8 - Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-8-net-loss-per-share-basic-and-diluted-net-loss-per-share-details Note 8 - Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details) Details 55 false false R56.htm 055 - Disclosure - Note 9 - Share based Compensation (Details Textual) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-9-share-based-compensation-details-textual Note 9 - Share based Compensation (Details Textual) Details http://www.beyondspringpharma.com/20201231/role/statement-note-9-share-based-compensation-tables 56 false false R57.htm 056 - Disclosure - Note 9 - Share based Compensation - Restricted Share Activities (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-9-share-based-compensation-restricted-share-activities-details Note 9 - Share based Compensation - Restricted Share Activities (Details) Details 57 false false R58.htm 057 - Disclosure - Note 9 - Share based Compensation - Options Activities (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-9-share-based-compensation-options-activities-details Note 9 - Share based Compensation - Options Activities (Details) Details 58 false false R59.htm 058 - Disclosure - Note 9 - Share based Compensation - Fair Value Assumptions (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-9-share-based-compensation-fair-value-assumptions-details Note 9 - Share based Compensation - Fair Value Assumptions (Details) Details 59 false false R60.htm 059 - Disclosure - Note 9 - Share based Compensation - Share-based Compensation Expense (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-9-share-based-compensation-sharebased-compensation-expense-details Note 9 - Share based Compensation - Share-based Compensation Expense (Details) Details 60 false false R61.htm 060 - Disclosure - Note 10 - Employee Defined Contribution Plan (Details Textual) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-10-employee-defined-contribution-plan-details-textual Note 10 - Employee Defined Contribution Plan (Details Textual) Details http://www.beyondspringpharma.com/20201231/role/statement-note-10-employee-defined-contribution-plan 61 false false R62.htm 061 - Disclosure - Note 11 - Restricted Net Assets (Details Textual) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-11-restricted-net-assets-details-textual Note 11 - Restricted Net Assets (Details Textual) Details http://www.beyondspringpharma.com/20201231/role/statement-note-11-restricted-net-assets 62 false false R63.htm 062 - Disclosure - Note 12 - Lease (Details Textual) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-12-lease-details-textual Note 12 - Lease (Details Textual) Details http://www.beyondspringpharma.com/20201231/role/statement-note-12-lease-tables 63 false false R64.htm 063 - Disclosure - Note 12 - Lease - Supplement Balance Sheet Information Related to Leases (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-12-lease-supplement-balance-sheet-information-related-to-leases-details Note 12 - Lease - Supplement Balance Sheet Information Related to Leases (Details) Details 64 false false R65.htm 064 - Disclosure - Note 12 - Lease - Maturities of Lease Liabilities (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-12-lease-maturities-of-lease-liabilities-details Note 12 - Lease - Maturities of Lease Liabilities (Details) Details 65 false false R66.htm 065 - Disclosure - Note 12 - Lease - Operating Lease Disclosure (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-12-lease-operating-lease-disclosure-details Note 12 - Lease - Operating Lease Disclosure (Details) Details 66 false false R67.htm 066 - Disclosure - Note 13 - Supplemental Balance Sheet Information - Other Current Liabilities (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-13-supplemental-balance-sheet-information-other-current-liabilities-details Note 13 - Supplemental Balance Sheet Information - Other Current Liabilities (Details) Details 67 false false R68.htm 067 - Disclosure - Note 14 - Contingently Redeemable Noncontrolling Interests (Details Textual) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-14-contingently-redeemable-noncontrolling-interests-details-textual Note 14 - Contingently Redeemable Noncontrolling Interests (Details Textual) Details http://www.beyondspringpharma.com/20201231/role/statement-note-14-contingently-redeemable-noncontrolling-interests-tables 68 false false R69.htm 068 - Disclosure - Note 14 - Contingently Redeemable Noncontrolling Interests - Redeemable Noncontrolling Interests, Net of Issuance Costs (Details) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-14-contingently-redeemable-noncontrolling-interests-redeemable-noncontrolling-interests-net-of-issuance-costs-details Note 14 - Contingently Redeemable Noncontrolling Interests - Redeemable Noncontrolling Interests, Net of Issuance Costs (Details) Details 69 false false R70.htm 069 - Disclosure - Note 15 - Forward Liability (Details Textual) Sheet http://www.beyondspringpharma.com/20201231/role/statement-note-15-forward-liability-details-textual Note 15 - Forward Liability (Details Textual) Details http://www.beyondspringpharma.com/20201231/role/statement-note-15-forward-liability- 70 false false All Reports Book All Reports bysi-20201231.xml bysi-20201231.xsd bysi-20201231_cal.xml bysi-20201231_def.xml bysi-20201231_lab.xml bysi-20201231_pre.xml http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2020-01-31 true true